Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Merck & Co. synthesizes new compounds for HIV infection

Oct. 29, 2020

Orion's OB-002H for prevention of HIV completes first-in-human study

Oct. 19, 2020

Test tube HIV enables replication insights

Oct. 14, 2020

T-cell 'repliclones' can thwart HIV drugs

Oct. 14, 2020

Gilead Sciences patents new HIV antivirals

Oct. 8, 2020

Merck & Co. identifies new HDAC inhibitors

Oct. 5, 2020

Gilead Sciences presents new PKC agonists

Sep. 23, 2020

Researchers discloses EFdA prodrugs for HIV infections

Sep. 18, 2020

Preclinical and phase I data presented for GSK-3640254

Sep. 2, 2020

Elite controller achieves none-in-a-billion status

Aug. 31, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...